Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 36
Merck Files Brief in Ernst Appeal, Says Causation Evidence Failed
MDL Plaintiff Says Her Health, Unemployment Warrant Remand
PSC: No 'Special Reasons' Preclude Ill. Law from Governing MDL
Texas Judge Dismisses Vioxx Plaintiff's Warning Claims as Preempted
Court Dismisses Vioxx Plaintiff's Skin Rash Claim for Failure to Prosecute
Plaintiffs Seek Discovery Concerning Pfizer's Interactions with Physicians
FDA Panel Recommends Against U.S. Approval for Merck's Arcoxia
N.J. Judge Dismisses Vioxx Securities Fraud Class Action as Time-Barred
